Press-release for stocks

Prices are updated after-hours

therapeutics crawled date : 2022 - 03 - 31

save search

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-03-31 (Crawled : 23:00) - globenewswire.com
SRPT | $117.065 0.09% 0.09% 440K

Health Technology

| 49.72% | O: 0.38% H: 5.42% C: 5.28%
nasdaq therapeutics granted grant

Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
SLNO | $40.32 7.41% 6.89% 420K

Health Technology

| 17143.91% | O: 6.11% H: 0.04% C: -3.46%
therapeutics results

Scientist I – Neuroscience/Translational Biology
Published: 2022-03-31 (Crawled : 22:00) - regulusrx.com
RGLS | $2.25 2.27% 2.22% 100K

Health Technology

| 638.26% | O: 1.11% H: 9.36% C: 7.9%

TransCode Therapeutics Reports 2021 Results; Provides Business UpdateCompany to host investor update call Thursday, April 7, at 4:30 p.m. ET
Published: 2022-03-31 (Crawled : 22:00) - biospace.com/
RNAZ | $0.461 0.44% 0.43% 100K

Professional, Scientific, and T...

| -99.16% | O: -1.1% H: 8.52% C: 6.67%
therapeutics

Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-31 (Crawled : 21:00) - globenewswire.com
FNCH | $2.79 20.78% 17.2% 510K

Professional, Scientific, and T...

| -54.08% | O: -0.6% H: 3.2% C: -5.6%
therapeutics results

Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
Published: 2022-03-31 (Crawled : 17:00) - biospace.com/
WINT | $5.52 1.28% 1.27% 81K

Health Technology

| -70.69% | O: -0.86% H: 1.74% C: -0.87%
therapeutics results

HighTide Therapeutics Appoints Myleen Leoncavallo as SVP Regulatory Affairs and Quality Assurance
Published: 2022-03-31 (Crawled : 17:00) - biospace.com/
MIRM | $24.4 0.95% 0.94% 420K

Health Technology

| 10.11% | O: -0.36% H: 1.23% C: 0.69%
therapeutics

Jasper Therapeutics to Present Updated Data on JSP191 Conditioning in SCID Patients at the 2022 Clinical Immunology Society Annual Meeting
Published: 2022-03-31 (Crawled : 16:00) - biospace.com/
JSPR | $22.0 -2.31% -2.36% 78K

| 572.24% | O: 2.69% H: 7.27% C: 3.2%
jsp191 immunology therapeutics

Cidara Therapeutics Announces the Completion of Dosing the First Cohort of Healthy Volunteers in the Phase 1 Trial of CD388 in Development for Universal Prevention and Treatment of Seasonal and Pandemic Influenza
Published: 2022-03-31 (Crawled : 16:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M

Health Technology

| -16.28% | O: 0.8% H: 0.0% C: 0.0%
CDTX | News | $0.5141 0.04% 0.04% 1.9M

Health Technology

| -38.94% | O: 1.77% H: 1.56% C: -2.04%
cd388 treatment trial therapeutics influenza phase 1

New Analysis Finds UPLIZNA® (inebilizumab-cdon) Effective for People with Newly-Presenting Neuromyelitis Optica Spectrum Disorder (NMOSD)
Published: 2022-03-31 (Crawled : 16:00) - biospace.com/
HZNP | $116.3 0.03% 29M

Health Technology

| 9.91% | O: 0.44% H: 0.4% C: -1.01%
uplizna

Sorrento Reports FDA Clearance for the Commencement of a Phase 2/3 Study for Abivertinib in Treatment of Hospitalized Patients With Severe Pneumonia Due to COVID-19
Published: 2022-03-31 (Crawled : 14:00) - biospace.com/
SRNE | $0.015 -8.85% 140K

Health Technology

| -99.58% | O: 1.27% H: 0.26% C: -2.92%
covid-19 treatment fda clearance phase 2

Acer Therapeutics Regains Compliance with Nasdaq Listing Standard
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
ACER | $0.9 -3.61% 420K

Health Technology

| -68.97% | O: -1.72% H: 4.91% C: 1.75%
nasdaq therapeutics

Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call Call Scheduled for Today, Thursday, March 31, 2022 at 5:00 pm ET
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
VVOS | $2.64 -1.12% 35K

Health Technology

| -0.38% | O: 8.68% H: 0.0% C: -6.94%
conference therapeutics results

R&D Efforts for Alzheimer's Therapies on the Rise with over 120 Drugs in Development
Published: 2022-03-31 (Crawled : 13:20) - prnewswire.com
LGVN | $1.79 -4.28% -4.47% 270K

| -72.17% | O: 39.73% H: 51.65% C: 46.96%
MESO | $5.97 7.96% 7.37% 630K

Health Technology

| 28.6% | O: 0.23% H: 0.0% C: -2.09%
DNLI | $16.11 0.75% 0.74% 1.1M

Health Technology

| -50.65% | O: 4.91% H: 0.0% C: -5.35%
SAVA M | $20.54 0.19% 0.19% 500K

Health Technology

| -46.81% | O: 0.34% H: 1.24% C: -3.96%
ALEC | $5.33 3.1% 3.0% 550K

Health Technology

| -64.34% | O: 0.48% H: 1.72% C: -2.2%
drug therapy alzheimer's alzheimer’s

Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
TENX | $3.59 0.84% 0.84% 12K

Health Technology

| 328.92% | O: 2.17% H: 0.0% C: -4.53%
therapeutics results

Celsion Corporation Reports 2021 Financial Results and Provides Business Update
Published: 2022-03-31 (Crawled : 13:20) - biospace.com/
NKTR | News | $1.415 4.04% 3.89% 1.1M

Health Technology

| -75.58% | O: 1.97% H: 0.0% C: -5.11%
corporation results

Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board
Published: 2022-03-31 (Crawled : 13:00) - biospace.com/
SIGY | $0.15 -1.53% 47K

| Email alert Add to watchlist
therapeutics

Agile Therapeutics® Announces First Twirla® Commercial Targeting Gen Z
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
AGRX | $0.394 0.0% 16K

Health Technology

| 62.57% | O: -4.13% H: 1.0% C: -8.91%
therapeutics twirla transdermal system contraceptive commercialization

Ventus Therapeutics Appoints Christine Ha as Chief Financial Officer
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
MS | News | $93.76 1.81% 0.12% 6.4M

Finance

| 0.35% | O: -2.24% H: 0.0% C: 0.0%
therapeutics

Abeona Therapeutics Announces Strategy Update and 2021 Financial Results
Published: 2022-03-31 (Crawled : 12:20) - biospace.com/
ATXI | $0.1301 1.66% 280K

Health Technology